Venus Concept Inc. (VERO) - Dilution Analysis

10-Q filing | 1.9M shares outstanding

8-K filing: Venus Concept Inc. entered into an Exchange Agreement with Madryn Health Partners, LP and Madryn Health Partners (Cayman Master), LP to exchange existing notes for 545,335 shares of Series Y Convertible Preferred Stock at $21.05 per share, closing on September 30, 2025.

10-Q filing | 1.9M shares outstanding

8-K filing: Venus Concept Inc. completed an exchange agreement on June 30, 2025, issuing 120,491 and 205,160 shares of Series Y Convertible Preferred Stock to Madryn Health Partners, LP and Madryn Health Partners (Cayman Master), LP, respectively, at a price of $19.96 per share. ($10.6M proceeds)

S-1 filing: This prospectus relates to the resale of up to 899,870 shares of common stock issuable upon exercise of outstanding warrants.

8-K filing: Venus Concept Inc. closed a registered direct offering on June 9, 2025, issuing 434,720 shares of common stock at $2.65 per share, raising gross proceeds of approximately $1.15 million. ($1.15M proceeds)

10-Q filing | 0.7M shares outstanding

8-K filing: Venus Concept Inc. completed a registered direct offering on April 14, 2025, selling 386,700 shares of common stock at $4.06 per share, raising gross proceeds of approximately $1.57 million. ($1.57M proceeds)

8-K filing: Venus Concept Inc. completed a registered direct offering on April 10, 2025, selling 328,573 shares of common stock at $3.50 per share, raising gross proceeds of approximately $1.1 million. ($1.1M proceeds)

8-K filing: Venus Concept Inc. completed an exchange agreement involving the issuance of Series Y Convertible Preferred Stock in exchange for existing notes, and the company amended its certificate of designations which clarified that the conversion ratio of Series Y Preferred Stock-to-Common Stock is 1-for-9.0909 (instead of 1-for-100) following the 1-for-11 reverse split of the Common Stock, which occurred on March 3, 2025. ($10.97M proceeds)

10-K filing | 0.7M shares outstanding

8-K filing: Stock split 1-for-11 | Outstanding: 7,255,000 → 659,479

10-Q filing | 7.3M shares outstanding

S-3 filing: Venus Concept Inc. may offer and sell up to $30,368,647.94 in the aggregate of common stock, preferred stock, and debt securities from time to time in one or more offerings.

8-K filing: Venus Concept Inc. exchanged debt for new secured notes and 203,583 shares of Series Y Convertible Preferred Stock, and amended the Certificate of Designations to increase the authorized number of Series Y Preferred Stock from 600,000 to 900,000.

10-Q filing | 6.6M shares outstanding

8-K filing: Venus Concept Inc. entered into an Exchange Agreement with Madryn Health Partners, exchanging $35,000,000 in debt for $17,142,009 in new secured convertible notes and 576,986 shares of newly-created Series Y Convertible Preferred Stock.

10-Q filing | 5.8M shares outstanding

S-3 filing: The filing relates to the resale of up to 1,644,400 shares of common stock by selling stockholders, some of which are issuable upon conversion of notes and to pay accrued interest.

S-1 filing: This prospectus relates to the resale of up to 874,990 shares of common stock issuable upon exercise of outstanding warrants by the selling stockholders.

10-K filing | 5.4M shares outstanding

8-K filing: Venus Concept Inc. closed a registered direct offering and concurrent private placement on February 27, 2024, issuing 817,748 shares of common stock at $1.465 per share, raising gross proceeds of approximately $1.2 million. ($1.2M proceeds)

8-K filing: Venus Concept Inc. issued and sold $2,000,000 in secured subordinated convertible notes to EW Healthcare Partners, L.P. and EW Healthcare Partners-A, L.P., with a potential conversion into a maximum of 1,598,721 shares of Common Stock at an initial conversion price of approximately $1.251 per share.

S-3 filing: This S-3 filing is for the resale of up to 1,229,393 shares of common stock by selling stockholders, issuable upon conversion of Series X Convertible Preferred Stock.

S-3/A filing: This S-3/A filing, dated 2023-11-22, relates to the resale of up to 1,090,402 shares of common stock by selling stockholders, issuable upon conversion of outstanding shares of senior convertible preferred stock.

10-Q filing | 5.5M shares outstanding

8-K filing: Venus Concept Inc. consummated the fourth sale in a private placement, selling 502,513 shares of Senior Preferred Stock to EW Healthcare Partners for $2,000,000 on October 20, 2023. ($2.0M proceeds)

8-K filing: Venus Concept Inc. issued 248,755 shares of Series X Convertible Preferred Stock at $20.10 per share in exchange for a portion of outstanding secured convertible notes. ($5.0M proceeds)

8-K filing: Venus Concept Inc. sold 292,398 shares of Senior Preferred Stock to EW Healthcare Partners for $1,000,000 in a private placement on September 8, 2023. ($1.0M proceeds)

10-Q filing | 5.5M shares outstanding

S-3 filing: This S-3 filing relates to the resale of up to 2,082,426 shares of common stock by selling stockholders, issuable upon conversion of outstanding shares of senior convertible preferred stock. The company will not receive any proceeds from the sale.

8-K filing: Venus Concept Inc. completed the second sale in a private placement, selling 500,000 shares of Senior Preferred Stock to EW Healthcare Partners for $2,000,000 on July 12, 2023. ($2.0M proceeds)

10-Q filing | 5.2M shares outstanding

8-K filing: Stock split 1-for-15 | Outstanding: 77,125,328 → 5,141,688

10-K filing | 77.1M shares outstanding

S-3 filing: This S-3 filing relates to the resale of up to 33,600,000 shares of common stock by selling stockholders.

8-K filing: Venus Concept Inc. filed a Certificate of Designations for Voting Convertible Preferred Stock, authorizing 4,100,000 shares, and amended the Nonvoting Preferred Certificate to eliminate restrictions on Common Stock issuance upon conversion.

10-Q filing | 65.3M shares outstanding

10-Q filing | 64.1M shares outstanding

8-K filing: Venus Concept Inc. entered into a purchase agreement with Lincoln Park Capital Fund, LLC, allowing the Company to sell up to $11,000,000 of its common stock to Lincoln Park.

10-Q filing | 64.0M shares outstanding

10-K filing | 64.0M shares outstanding

S-3 filing: This prospectus relates to the resale of up to 13,599,173 shares of common stock by selling stockholders.

8-K filing: Venus Concept, Inc. entered into a stock purchase agreement to issue and sell 9,808,418 shares of common stock and 3,790,755 shares of nonvoting convertible preferred stock for gross proceeds of $17 million. ($34.0M proceeds)

10-Q filing | 54.1M shares outstanding

S-3 filing: Venus Concept Inc. may offer and sell up to $55,047,990.59 in the aggregate of common stock, preferred stock, and debt securities from time to time in one or more offerings.

10-Q filing | 54.1M shares outstanding

10-Q filing | 53.7M shares outstanding

10-K filing | 54.0M shares outstanding

S-3 filing: This S-3 filing relates to the resale of up to 8,213,881 shares of common stock by selling stockholders, issuable upon conversion of outstanding 8% secured subordinated convertible notes.

10-Q filing | 40.5M shares outstanding

10-Q filing | 40.3M shares outstanding

10-Q filing | 29.8M shares outstanding

S-3 filing: This S-3 filing relates to the resale of up to 15,575,000 shares of common stock by selling stockholders.

10-K filing | 32.2M shares outstanding

S-3 filing: This S-3 filing registers 16,387,026 shares of common stock for resale by selling stockholders, including 12,465,110 issued and outstanding shares and 3,921,916 shares issuable upon exercise of warrants.